Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report
Goss, P.E.; Burkes, R.; Rudinskas, L.; King, M.; Chow, W.; Myers, R.; Davidson, M.; Poldre, P.; Crump, M.; Sutton, D.
Seminars in Hematology 31(2 Suppl. 3): 23-29
1994
ISSN/ISBN: 0037-1963 PMID: 8073303 Document Number: 439108
Document emailed within 1 workday
Related Documents
Chuang, M.W.; Tzeng, C.H.; Chiou, T.J.; Chiu, C.F.; Hsieh, R.K.; Liu, J.H.; Chen, P.M. 1988: A comparative trial of C-novantrone OP(CNOP) vs C-adriamycin OP(CHOP) in the treatment of stage II-IV malignant lymphoma--the preliminary report Zhonghua Yi Xue Za Zhi 41(1): 51-56Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Hainsworth, J.D.; Johnson, D.H.; Greco, F.A. 1992: Chronic etoposide schedules in the treatment of non-Hodgkin's lymphoma Seminars in Oncology 19(6 Suppl 14: 13-18
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Yang, K. 1984: Preliminary report on the immunopathologic studies of non-Hodgkin's lymphoma Zhonghua Zhong Liu Za Zhi 6(2): 101-105
Angrilli, F.; Pennese, E.; Di Marzio, A.; Liberatore, E.; Di Lorenzo, R.; Fioritoni, G. 2002: A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin's lymphoma Haematologica 87(11): 1227-1229
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Soga, T.; Sakane, Y.; Fukuhara, S. 1997: An elderly case whose residual malignant lymphoma was completely remitted by oral etoposide treatment using unusual dosing schedule Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(3): 361-364
Bogusławska-Jaworska, J.; Grześkowiak-Melanowska, J.; Kaczmarek, M.; Kościelniak, E.; Legutko, L.; Sońta-Jakimczyk, D.; Sroczyńska, M.; Wojcik, Z. 1980: Preliminary therapeutic results of treatment of non-Hodgkin lymphoma in children according to the BACOP program Pediatria Polska 55(2): 207-210
Li, Q.-b.; Tang, X.-q.; Zhao, Z.-g.; Wang, H.-x.; You, Y.; Chen, Z.-c.; Zou, P. 2007: Role of amifostine against the effect of etoposide on non-Hodgkin lymphoma bone marrow derived mesenchymal stem cells: an in vitro experiment Zhonghua Yi Xue Za Zhi 87(12): 812-815
Yuki, K.; Kodama, Y.; Emoto, K.; Yukawa, O.; Onda, J.; Uozumi, T. 1989: A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Pt 1): 2651-2654
Kositwattanarerk, A.; Changmuang, W.; Sangsuriyan, J.; Thongklam, K.; Sritara, C.; Utamakul, C.; Chamroonrat, W.; Thamnirat, K.; Anongpornyochkul, Y.; Chancharunee, S. 2013: 131I-rituximab treatment in patient with relapsed non-Hodgkin's lymphoma: the first case report in Thailand Journal of the Medical Association of Thailand 96(6): 756-760
Young, R.C. 1992: Etoposide in the treatment of non-Hodgkin's lymphomas Seminars in Oncology 19(6 Suppl 13: 19-25
Moriya, A.; Ikeda, A.; Yokoyama, N.; Yokoyama, T.; Abe, Y.; Miyamoto, K. 1993: A case of gastric malignant lymphoma markedly responding to chronic daily and oral administration of low-dose etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2229-2233
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91
Hansen, M.M.; Bloomfield, C.D.; Jørgensen, J.; Ersbøll, J.; Pedersen-Bjergaard, J.; Blom, J.; Nissen, N.I. 1980: VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas Cancer Treatment Reports 64(10-11): 1135-1137
Chewaskulyong, B.; Thongprasert, S. 1998: Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer Journal of the Medical Association of Thailand 81(1): 37-41
Behringer, K.; Wildt, L.; Mueller, H.; Mattle, V.; Ganitis, P.; van den Hoonaard, B.; Ott, H.W.; Hofer, S.; Pluetschow, A.; Diehl, V.; Engert, A.; Borchmann, P. 2010: No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase Ii trial from the German Hodgkin Study Group Annals of Oncology: Official Journal of the European Society for Medical Oncology 21(10): 2052-2060
Pecorari, P.; Melato, M. 1998: Non-Hodgkin's lymphoma (NHL) of the oral cavity Anticancer Research 18(2b): 1299-1302
Morrison, V.A. 2007: Non-Hodgkin's lymphoma in the elderly. Part 1: Overview and treatment of follicular lymphoma Oncology 21(9): 1104-1110